The relationship between chronic obstructive pulmonary disease (COPD) and chronic bronchitis ... including diagnostic criteria and management of acute exacerbation of CB (AECB) in the elderly ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Azithromycin taken daily at a dose of 250 mg was reported to significantly reduce the rate of COPD exacerbations in severe COPD patients over a period of 1 year. QoL measures and exacerbation ...

So a COPD exacerbation is a period where people with COPD will notice an acute deterioration in their symptoms. And these will probably last a few days, and they may experience shortness of breath ...

Azithromycin (as dihydrate) 100mg/5mL, 200mg/5mL; pwd for oral susp. Use packets only for doses equal to 1g. COPD: 500mg once daily for 3 days; or 500mg once for 1 day, then 250mg once daily for 4 ...

Azithromycin (as dihydrate) 1g/packet (single-dose); pwd for oral susp. Use packets only for doses equal to 1g. COPD: 500mg once daily for 3 days; or 500mg once for 1 day, then 250mg once daily ...

RAs, and DPP-4is may offer benefits for patients with COPD, but clinical evidence comparing their effectiveness in reducing ...

SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a reduced risk of COPD exacerbations in patients with type 2 ...

Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD ...